Dramatic Improvement of Long Lasting Post-Inflammatory Hyperpigmentation by Oral and Topical Tranexamic Acid

Jae Kyung Kim, Sung Eun Chang, Chong Hyun Won, Mi Woo Lee, Jee Ho Choi, Kee Chan Moon

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

DOI: 10.4236/jcdsa.2012.22014                

Abstract

Post-inflammatory hyperpigmentation is common problem, but its treatment still remains challenging. Tranexamic acid has been used to treat or prevent excessive bleeding loss in various medical conditions. There have been some reports of the effect of oral and topical tranexamic acid for treatment of pigmented disorder. Herein we report on a case of female patient who showed improvement of PIH after oral and topical tranexamic acid administration.

Keywords

Post-Inflammatory Hyperpigmentation; Tranexamic Acid

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	N. L. Lacz, J. Vafaie, N. I. Kihiczak and R. A. Schwartz, “Postinflammatory Hyperpigmentation: A Common but Troubling Condition,” International Journal of Dermatology, Vol. 43, No. 5, 2004, pp. 362-365. doi:10.1111/j.1365-4632.2004.02267.x
[2]	K. Maeda and M. Naganuma, “Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation induced pigmentation,” Journal of Photochemistry and Photobiology, Vol. 47, No. 2, 1998, pp. 130-141.
[3]	J. H. Lee, J. G. Park, S. H. Lim, J. Y. Kim, K. Y. Ahn, M. Y. Kim and Y. M. Park, “Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical Trial,” Dermatologic Surgery, Vol. 32, No 5, 2006, pp. 626-631. doi:10.1111/j.1524-4725.2006.32133.x
[4]	The Minister of Health, Labour and Welfare, “The Japanese Pharmacopoeia,” 14th Edition, Hirokawa Publishing, Tokyo, 2002.
[5]	K. Maeda and Y. Tomita, “Mechanism of the Inhibitory Effect of Tranexamic Acid on Melanogenesis in Cultured Human Melanocytes in the Presence of KeratinocyteConditioned Medium,” Journal of Health Science, Vol. 53, No. 4, 2007, pp. 389-396. doi:10.1248/jhs.53.389
[6]	A. Manosroi, K. Podjanasoonthon and J. Manosroi, “Development of Novel Topical Tranexamic Acid Liposome Formulations,” International Journal of Pharmaceutics, Vol. 235, No. 1, 2002, pp. 61-70. doi:10.1016/S0378-5173(01)00980-2